Report of SARS-CoV-2 B1.1.7 Lineage in Morocco

Mouna Ouadghiri; Tarik Aanniz; Abdelomunim Essabbar; Myriam Seffar; Hakima Kabbaj; Ghizlane El Amin; Amal Zouaki; Saaïd Amzazi; Lahcen Belyamani; Azeddine Ibrahimi

doi:10.1128/MRA.00240-21

Report of SARS-CoV-2 B1.1.7 Lineage in Morocco

Microbiol Resour Announc. 2021 Apr 22;10(16):e00240-21. doi: 10.1128/MRA.00240-21.

Authors

Affiliations

¹ Medical Biotechnology Laboratory (MedBiotech), Bioinova Research Center, Rabat Medical and Pharmacy School, Mohammed V University, Rabat, Morocco m.ouadghiri@um5r.ac.ma.
² Medical Biotechnology Laboratory (MedBiotech), Bioinova Research Center, Rabat Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.
³ Laboratoire Central de Virologie, Centre Hospitalo-Universitaire Ibn Sina, Hôpital des Spécialités, Rabat, Morocco.
⁴ Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
⁵ Emergency Department, Military Hospital Mohammed V, Rabat Medical and Pharmacy School, Mohammed V University, Rabat, Morocco.

Abstract

Here, we report the near-complete genome sequence and the genetic variations of a clinical sample of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) harboring the N501Y mutation assigned to the B.1.1.7 lineage. The sample was collected from a nasopharyngeal swab of a female patient from Temara, Morocco, and the sequencing was done using Ion S5 technology.